The Leukemia & Lymphoma Society Names John P. Leonard, MD its 2016 Manhattan Light the Night Corporate Chair

John Leonard, MD
John P. Leonard, MD

The New York City Chapter of the Leukemia & Lymphoma Society (LLS) named Lymphoma Program Director, John P. Leonard, MD of Weill Cornell Medicine and NewYork-Presbyterian the corporate chair for Manhattan’s 2016 Light the Night event. Light the Night brings together friends, family members, and co-workers who form fundraising teams to support the lifesaving research, that will improve the quality of live for all patients with blood cancers.

“Supporting Light The Night is a powerful way to partner with LLS to raise critical funds for blood cancer research,” said Dr. Leonard. “I am honored to serve as the chair and look forward to encouraging other organizations and businesses to join me in supporting LLS by participating in Light The Night.”

Each year, Light The Night brings together friends, family members and co-workers who form fundraising teams to support lifesaving research and improve the quality of lives of patients and their families. Participants in nearly 200 communities across North America join together carrying illuminated lanterns to take steps to end cancer – white for survivors, red for supporters and gold in memory of loved ones lost to cancer.

The 2016 Manhattan Light the Night event will be hosted by Weill Cornell Medicine and NewYork Presbyterian. This year it will be held on Thursday, October 6th at 5:30pm at Rumsey Playfield in Central Park.

You can join, or donate to the Weill Cornell Medicine and NewYork Presbyterian on our Light the Night team page.

New Developments in Lymphoma – Summer 2015 Newsletter

The Lymphoma Program has published the summer 2015 edition of the New Developments in Lymphoma Newsletter.

Please look to this space for further announcements of future newsletter issues, or add your name to our mailing list.

 

Dr. Ari Melnick: A New Day Dawning for Personalized Cancer Treatments

Weill Cornell’s Dr. Melnick also discusses why turning science into medicine is happening much more rapidly.